PAX8 and nonpapillary renal cell carcinoma: PAX8 maintains ccRCC proliferative capacity by supporting the expression of MYC. 14Furthermore, compared to P81Ctrl(A) cells, P81S11/2(LT) cells showed increased MYC expression levels based on our RNA-seq data (Figure 5H).